S. Aryal

CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer

Ju-Seog Lee, T. Choi, I. Kang, 2015, Oncotarget.

Identification and functional implications of pseudouridine RNA modification on small noncoding RNAs in the mammalian pathogen Trypanosoma brucei

K. S. Rajan, Y. Pilpel, R. Unger, 2022, The Journal of biological chemistry.

Developmentally Regulated Novel Non-coding Anti-sense Regulators of mRNA Translation in Trypanosomabrucei

K. S. Rajan, R. Unger, C. Tschudi, 2020, iScience.

Prognostic value and their clinical implication of 89-gene signature in glioma

Ju-Seog Lee, T. Choi, I. Kang, 2016, Oncotarget.

Pseudouridines on Trypanosoma brucei spliceosomal small nuclear RNAs and their implication for RNA and protein interactions

K. S. Rajan, R. Unger, C. Tschudi, 2019, Nucleic acids research.

The Spliced Leader RNA Silencing (SLS) Pathway in Trypanosoma brucei Is Induced by Perturbations of Endoplasmic Reticulum, Golgi Complex, or Mitochondrial Protein Factors: Functional Analysis of SLS-Inducing Kinase PK3

K. S. Rajan, H. Senderowitz, S. Michaeli, 2021, mBio.

The spliced leader RNA silencing (SLS) pathway in Trypanosoma brucei is induced by perturbations of endoplasmic reticulum, Golgi, or mitochondrial proteins factors and functional analysis of SLS inducing kinase, PK3

K. S. Rajan, H. Senderowitz, S. Michaeli, 2021, bioRxiv.

Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis.

S. Michaeli, S. Kannan, Yifat Harel, 2021, Journal of controlled release : official journal of the Controlled Release Society.

A single pseudouridine on rRNA regulates ribosome structure and function in the mammalian parasite Trypanosoma brucei

K. S. Rajan, Schraga Schwartz, A. Bashan, 2023, Nature communications.

Structural and mechanistic insights into the function of Leishmania ribosome lacking a single pseudouridine modification

K. S. Rajan, Y. Pilpel, A. Bashan, 2024, Cell reports.